Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
about
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypesLive attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaquesCharacterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profilingEx vivo SIV-specific CD8 T cell responses in heterozygous animals are primarily directed against peptides presented by a single MHC haplotypeTetherin/BST-2: Restriction Factor or Immunomodulator?Recognition of HIV-1 peptides by host CTL is related to HIV-1 similarity to human proteins.Distribution, persistence, and efficacy of adoptively transferred central and effector memory-derived autologous simian immunodeficiency virus-specific CD8+ T cell clones in rhesus macaques during acute infection.Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activityEffect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatmentPolymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines.Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infectionExperimental depletion of CD8+ cells in acutely SIVagm-infected African Green Monkeys results in increased viral replication.The role of MHC class I allele Mamu-A*07 during SIV(mac)239 infectionCD8+ lymphocytes do not mediate protection against acute superinfection 20 days after vaccination with a live attenuated simian immunodeficiency virusTransduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.Lineage-specific T-cell reconstitution following in vivo CD4+ and CD8+ lymphocyte depletion in nonhuman primates.Similar T-cell immune responses induced by group M consensus env immunogens with wild-type or minimum consensus variable regions.Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge.Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaquesCD8+ cell depletion accelerates HIV-1 immunopathology in humanized mice.Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particlesVaccination with live attenuated simian immunodeficiency virus causes dynamic changes in intestinal CD4+CCR5+ T cells.Transcriptionally abundant major histocompatibility complex class I alleles are fundamental to nonhuman primate simian immunodeficiency virus-specific CD8+ T cell responses.Simian immunodeficiency virus SIVmac239Deltanef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypes compared to a DNA prime/adenovirus type 5 boost regimen in rhesus macaques.Role of CD8+ cells in controlling replication of nonpathogenic Simian Immunodeficiency Virus SIVmac1A11.Characteristics of CD8+ T cell subsets in Chinese patients with chronic HIV infection during initial ART.Significant protection against high-dose simian immunodeficiency virus challenge conferred by a new prime-boost vaccine regimen.Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus.An evolutionary role for HIV latency in enhancing viral transmission.Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus.The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus.Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination.Dorsal root ganglia damage in SIV-infected rhesus macaques: an animal model of HIV-induced sensory neuropathy.Induction of CD8+ cells able to suppress CCR5-tropic simian immunodeficiency virus SIVmac239 replication by controlled infection of CXCR4-tropic simian-human immunodeficiency virus in vaccinated rhesus macaques.Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVΔnef live attenuated vaccineLymph node T cell responses predict the efficacy of live attenuated SIV vaccines.Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals
P2860
Q24682603-0BBA5F67-7E17-4D93-BEB7-B8A16EFCD40CQ27305234-30CA9C4B-AE42-44B6-A412-11568AA9999CQ27320870-54655F81-33B8-4FCD-A5A4-A102FBCE7940Q27322650-D64CBB65-E813-409C-85B5-E814B7059A8CQ30385433-76920297-EAF7-4F87-B542-F48012E07172Q33296987-E8F10CCB-9629-4A4F-9A69-4232D6746EEDQ33554940-EFC3FBDA-DFAC-4CA7-BBED-2C49E14F7E93Q33606773-FA592164-845E-4555-9F3E-736EB86AD465Q33812154-C42A6591-677D-487F-B997-D9BD3BFEB100Q33843308-DF5DC9B1-3487-40B2-91D9-2773FA75132FQ33847673-CE2AA7FF-3819-449B-8493-BD8693AF01C0Q33854564-B28E0754-7256-4014-A077-B290BE6454D8Q33869806-C2B4196A-0A40-4924-B751-1E669B2FBB7FQ33888012-505415E6-3928-4EE4-8100-447D1EAA63F6Q33952695-BDF3A9FF-E893-4136-905E-D6C8F39E73B7Q33984208-A0DCEC5E-0748-468F-A4B5-0A1A509AF133Q34008900-7E49BB56-C4DE-421B-9EEB-573EF3F0B083Q34052601-8C5373A6-68C3-46DC-BB1F-6BF7938B69B7Q34103170-1C912C1E-726D-408A-BE9D-7AAEFC3438BCQ34120102-6F0334FC-4139-45BD-8A68-52E1477DD249Q34228494-952E016D-4E94-4D4D-AA5A-688648A3674AQ34433569-ED445B97-38DD-49C5-A220-37A81881558BQ34465510-D05034D4-CB21-4853-8195-4A9985400A33Q34573745-E5BD4AE4-9F8B-4194-AE70-0FA4A3889AA5Q34742324-B0B4DCE1-D514-46E4-A220-F76601174604Q34742502-1EAF2811-5EAB-410A-8B4D-5B0DB942F7ACQ34767799-566AD840-E54E-4D3F-BEB7-22F95BE065CBQ34778365-A8713441-6D31-46C7-A118-AD174DB574B3Q35076961-3AE52D93-FA80-4D67-B46B-C5980EFC929FQ35784787-D9425890-CF9D-4313-AAF8-7ED9A8C101B9Q35807225-B3798417-D10C-4088-85D5-857747824274Q35826784-94EDEB34-DE38-4BA7-90E7-0F246111BA66Q35849808-4EDA3BF4-E050-428B-BD64-1B87633F8B55Q35857708-F962BDCC-1928-41AF-A70D-D39103A92DA0Q35952086-928B9647-80E9-4AD0-955A-9BF3C08D7FEDQ36314997-87710F75-246E-456C-8D51-1243C4324064Q36315197-D67305BD-0789-46CE-955A-9C0D1FD934C2Q36319685-173FBA45-C5F6-4E51-A5D1-97A9CDA3217EQ36385484-F71A5895-2F32-4D75-A6A0-043674C67589Q36498151-BC1BA413-3F02-4810-82E0-4AAEBE43156E
P2860
Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Effects of in vivo CD8(+) T ce ...... mmunodeficiency virus vaccine.
@ast
Effects of in vivo CD8(+) T ce ...... mmunodeficiency virus vaccine.
@en
type
label
Effects of in vivo CD8(+) T ce ...... mmunodeficiency virus vaccine.
@ast
Effects of in vivo CD8(+) T ce ...... mmunodeficiency virus vaccine.
@en
prefLabel
Effects of in vivo CD8(+) T ce ...... mmunodeficiency virus vaccine.
@ast
Effects of in vivo CD8(+) T ce ...... mmunodeficiency virus vaccine.
@en
P2093
P2860
P921
P356
P1476
Effects of in vivo CD8(+) T ce ...... immunodeficiency virus vaccine
@en
P2093
A S Perelson
K J Metzner
M Di Mascio
R I Connor
P2860
P304
P356
10.1084/JEM.191.11.1921
P407
P577
2000-06-01T00:00:00Z